Advanced squamous lung carcinoma in a patient experiencing long-term survival following repeated responses to gemcitabine and cisplatin chemotherapy: A case report.

about

Advanced squamous lung carcinoma in a patient experiencing long-term survival following repeated responses to gemcitabine and cisplatin chemotherapy: A case report.

Item

http://www.wikidata.org/entity/Q35759003

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Advanced squamous lung carcino ...... n chemotherapy: A case report.

@ast

Advanced squamous lung carcino ...... n chemotherapy: A case report.

@en

type

Item

label

Advanced squamous lung carcino ...... n chemotherapy: A case report.

@ast

Advanced squamous lung carcino ...... n chemotherapy: A case report.

@en

prefLabel

Advanced squamous lung carcino ...... n chemotherapy: A case report.

@ast

Advanced squamous lung carcino ...... n chemotherapy: A case report.

@en

P1476

Advanced squamous lung carcino ...... n chemotherapy: A case report.

@en

P2093

Feng Peng

http://www.w3.org/2001/XMLSchema#string

Min Yu

http://www.w3.org/2001/XMLSchema#string

Shuang Zhang

http://www.w3.org/2001/XMLSchema#string

Yanying Li

http://www.w3.org/2001/XMLSchema#string

Zhenyu Ding

http://www.w3.org/2001/XMLSchema#string

P2860

Squamous cell carcinoma of the lung: molecular subtypes and therapeutic opportunities

Molecular pathology of lung cancer: key to personalized medicine.

Cancer statistics, 2014

Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy

Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy.

ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin

Exploring RNA transcription and turnover in vivo by using click chemistry.

Randomized international phase III trial of ERCC1 and RRM1 expression-based chemotherapy versus gemcitabine/carboplatin in advanced non-small-cell lung cancer.

Re-challenge chemotherapy with gemcitabine plus carboplatin in patients with non-small cell lung cancer.

P304

2874-2878

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2015.3097

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26137163

http://www.w3.org/2001/XMLSchema#string

P932

4473694

http://www.w3.org/2001/XMLSchema#string